Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -45.53 | 14.21 |
| PEG Ratio (TTM) | 0.75 | 2.12 |
| P/S Ratio (TTM) | 14.59 | 2.69 |
| P/B Ratio (TTM) | 2.54 | 2.48 |
| P/FCF Ratio (TTM) | -10.80 | 9.55 |
| Price to 5YR AVG Earnings Ratio | 37.80 | 16.23 |
| Price to 5YR AVG FCF Ratio | -59.44 | 4.40 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.58% | 5.50% |
| ROE (TTM) | -5.08% | 20.99% |
| Net Profit Margin (TTM) | -32.24% | -128.17% |
| ROIC 5YR AVG | 11.75% | 31.95% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -93.70% | 89.63% | 57.54% |
| Revenue | 15.53% | 79.67% | 49.19% |
| Net Income | -90.07% | 181.82% | 113.58% |
| Cash Flow | -92.67% | 1,253.15% | 782.91% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.93 | 1.82 |
| Quick Ratio (TTM) | 6.13 | 1.39 |
| D/E Ratio (TTM) | 0.88 | 0.42 |
| Interest Coverage (TTM) | -8.70 | 17.40 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.97 | 3.25 |
| LTL to 5YR AVG FCF | -15.24 | -3.71 |
| Shares Outstanding Growth 5YR AVG | 27.91% | 20.45% |